Age-dependent changes in NMDA-induced excitotoxicity and neuromodulatory effects of kynurenic acid and its analogue in mouse brain slices

Kynurenic acid (KYNA) is one of the main neuroprotective substances of the kynurenine pathway. KYNA plays an important role in various neurodegenerative and psychiatric diseases. Although KYNA has been shown to have neuroprotective effects, it cannot be used as a peripherally administered drug due t...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Balog Emma
Jenei Gyula
Magyariné Berkó Anikó
Lőrinczi Bálint
Szatmári István
Vécsei László
Toldi József
Kis Zsolt
Dokumentumtípus: Cikk
Megjelent: 2025
Sorozat:NEUROSCIENCE LETTERS 854
Tárgyszavak:
doi:10.1016/j.neulet.2025.138220

mtmt:36067612
Online Access:http://publicatio.bibl.u-szeged.hu/36377
LEADER 02565nab a2200313 i 4500
001 publ36377
005 20250331151057.0
008 250331s2025 hu o 000 eng d
022 |a 0304-3940 
024 7 |a 10.1016/j.neulet.2025.138220  |2 doi 
024 7 |a 36067612  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a eng 
100 1 |a Balog Emma 
245 1 0 |a Age-dependent changes in NMDA-induced excitotoxicity and neuromodulatory effects of kynurenic acid and its analogue in mouse brain slices  |h [elektronikus dokumentum] /  |c  Balog Emma 
260 |c 2025 
300 |a 7 
490 0 |a NEUROSCIENCE LETTERS  |v 854 
520 3 |a Kynurenic acid (KYNA) is one of the main neuroprotective substances of the kynurenine pathway. KYNA plays an important role in various neurodegenerative and psychiatric diseases. Although KYNA has been shown to have neuroprotective effects, it cannot be used as a peripherally administered drug due to its poor ability to cross the blood-brain barrier. To address this limitation, chemically modified KYNA analogues are being developed: SZR72 is one such analogue and has been shown to be protective in various animal models. Glutamate-induced excitotoxicity is a key factor in many neurodegenerative diseases. Therefore, we used the N-methyl-D-aspartate (NMDA)-induced excitotoxicity model to investigate the neuromodulatory agents. Using acute hippocampal slices from mouse brains, we investigated the potential neuroprotective effect of KYNA and its analogue, SZR72 on NMDA-induced excitotoxicity across different age groups of mice. The degree of tissue damage was assessed using biochemical and histological methods. In young animals (1- and 4-week-old), NMDA treatment caused no significant changes, and the cells were found to be resistant. However in older animals (8-week-old and 1-year-old), NMDA caused significant damage in cells and tissue structure, which was reduced by KYNA and SZR72 treatment. To our knowledge, this is the first study to compare the neuroprotective effects of KYNA and SZR72 in animals of different ages using an in vitro NMDA excitotoxicity model. 
650 4 |a Általános orvostudomány 
650 4 |a Klinikai orvostan 
700 0 1 |a Jenei Gyula  |e aut 
700 0 2 |a Magyariné Berkó Anikó  |e aut 
700 0 2 |a Lőrinczi Bálint  |e aut 
700 0 2 |a Szatmári István  |e aut 
700 0 2 |a Vécsei László  |e aut 
700 0 2 |a Toldi József  |e aut 
700 0 2 |a Kis Zsolt  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/36377/1/1-s2.0-S0304394025001089-main.pdf  |z Dokumentum-elérés